Author:
Park Jae-Keun,Lee Dong-Hun,Yuk Seong-Su,Tseren-Ochir Erdene-Ochir,Kwon Jung-Hoon,Noh Jin-Yong,Kim Byoung-Yoon,Choi Soo-Won,Kang Sang-Moo,Lee Joong-Bok,Park Seung-Yong,Choi In-Soo,Song Chang-Seon
Abstract
ABSTRACTIn this study, we developed Newcastle disease virus (NDV) virus-like particles (VLPs) expressing NDV fusion (F) protein along with influenza virus matrix 1 (M1) protein using the insect cell expression system. Specific-pathogen-free chickens were immunized with oil emulsion NDV VLP vaccines containing increasing dosages of VLPs (0.4, 2, 10, or 50 μg of VLPs/0.5-ml dose). Three weeks after immunization, the immunogenicity of the NDV VLP vaccines was determined using a commercial enzyme-linked immunosorbent assay (ELISA) kit, and a lethal challenge using a highly virulent NDV strain was performed to evaluate the protective efficacy of the NDV VLP vaccines. NDV VLP vaccines elicited anti-NDV antibodies and provided protection against a lethal challenge in a dose-dependent manner. Although the VLP vaccines containing 0.4 and 2 μg of VLPs failed to achieve high levels of protection, a single immunization with NDV VLP vaccine containing 10 or 50 μg could fully protect chickens from a lethal challenge and greatly reduced challenge virus shedding. Furthermore, we could easily differentiate infected from vaccinated animals (DIVA) using the hemagglutination inhibition (HI) test. These results strongly suggest that utilization of NDV VLP vaccine in poultry species may be a promising strategy for the better control of NDV.
Publisher
American Society for Microbiology
Subject
Microbiology (medical),Clinical Biochemistry,Immunology,Immunology and Allergy
Reference27 articles.
1. OIE. 2012. Chapter 2.3.14, Newcastle disease. In OIE terrestrial manual. OIE, Paris, France. http://www.oie.int/fileadmin/Home/fr/Health_standards/tahm/2.03.14_NEWCASTLE_DIS.pdf.
2. Virus-like particles in vaccine development;Roldão;Expert Rev. Vaccines,2010
3. Virus-like particles as universal influenza vaccines;Kang;Expert Rev. Vaccines,2012
4. Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development;Kushnir;Vaccine,2012
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献